Profile data is unavailable for this security.
About the company
Neuronetics, Inc. a vertically integrated, commercial stage, medical technology and healthcare company. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The Company provides more than 7.1 million treatments to over 1,95,000 patients.
- Revenue in USD (TTM)129.87m
- Net income in USD-44.50m
- Incorporated2001
- Employees716.00
- LocationNeuronetics Inc3222 Phoenixville PikeMALVERN 19355United StatesUSA
- Phone+1 (610) 640-4202
- Fax+1 (610) 640-4206
- Websitehttps://neurostar.com/neuronetics/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Positron Corp | 1.24m | -1.27m | 65.70m | 22.00 | -- | -- | -- | 53.11 | -0.0897 | -0.0897 | 0.0876 | -0.1109 | 0.5976 | 2.29 | 6.56 | -- | -61.35 | -224.13 | -- | -- | 32.98 | 9.85 | -102.67 | -201.87 | 0.0638 | -- | -- | -- | -10.06 | 0.2751 | 63.63 | -- | 4.36 | -- |
| QT Imaging Holdings Inc | 11.50m | -19.51m | 68.70m | 20.00 | -- | -- | -- | 5.98 | -2.09 | -2.09 | 1.27 | -0.939 | 1.20 | 1.34 | 6.57 | 574,821.50 | -204.52 | -- | -4,313.85 | -- | 50.81 | -- | -169.73 | -- | 0.4745 | -2.02 | 80.26 | -- | 11,987.88 | -- | -132.34 | -- | -- | -- |
| DarioHealth Corp | 24.73m | -37.11m | 69.54m | 196.00 | -- | 0.9294 | -- | 2.81 | -12.47 | -12.47 | 8.29 | 11.07 | 0.2173 | 2.22 | 6.51 | 126,183.70 | -37.17 | -63.89 | -42.41 | -75.30 | 56.86 | 34.31 | -171.09 | -262.34 | 4.02 | -69.69 | 0.2901 | -- | 32.86 | 29.04 | 35.47 | -- | 7.09 | -- |
| InspireMD Inc | 7.78m | -46.20m | 75.21m | 85.00 | -- | 1.16 | -- | 9.67 | -0.8396 | -0.8396 | 0.139 | 1.53 | 0.1207 | 1.93 | 4.46 | 91,517.65 | -71.65 | -60.63 | -83.34 | -71.77 | 24.91 | 20.76 | -593.89 | -377.98 | 6.17 | -- | 0.00 | -- | 12.96 | 13.50 | -60.70 | -- | 37.62 | -- |
| Sensus Healthcare Inc | 35.61m | -3.01m | 80.65m | 35.00 | -- | 1.58 | -- | 2.26 | -0.1847 | -0.1847 | 2.18 | 3.11 | 0.6028 | 1.32 | 2.71 | 1,017,400.00 | -5.09 | 13.01 | -5.66 | 14.98 | 47.95 | 61.32 | -8.44 | 19.45 | 5.27 | -- | 0.00 | -- | 71.31 | 8.93 | 1,270.52 | -- | -7.18 | -- |
| MaxCyte Inc | 34.42m | -45.63m | 82.14m | 114.00 | -- | 0.4555 | -- | 2.39 | -0.4298 | -0.4298 | 0.3243 | 1.69 | 0.149 | 0.7657 | 5.35 | 301,921.10 | -19.75 | -13.01 | -21.30 | -14.01 | 79.97 | 87.32 | -132.58 | -72.43 | 7.27 | -- | 0.00 | -- | -6.44 | 12.31 | -8.26 | -- | 5.37 | -- |
| Phaos Technlgy Hldngs (Cayman) Limited | 132.66k | -100.00bn | 84.98m | -- | -- | -- | -- | 640.59 | -- | -- | -- | -0.0604 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.3176 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Outset Medical Inc | 120.07m | -87.80m | 85.32m | 354.00 | -- | 0.6042 | -- | 0.7106 | -13.00 | -13.00 | 10.42 | 7.99 | 0.4212 | 1.35 | 3.57 | 339,178.00 | -30.80 | -40.67 | -35.82 | -46.80 | 37.70 | 15.62 | -73.12 | -140.08 | 5.77 | -8.29 | 0.4016 | -- | -12.80 | 49.79 | 25.94 | -- | -22.65 | -- |
| Xtant Medical Holdings Inc | 133.08m | 1.75m | 86.82m | 217.00 | 60.68 | 1.72 | 12.98 | 0.6524 | 0.0102 | 0.0102 | 0.9158 | 0.3599 | 1.30 | 1.22 | 5.78 | 613,285.70 | 1.71 | -11.38 | 2.57 | -16.17 | 62.02 | 59.37 | 1.32 | -9.64 | 1.06 | 1.57 | 0.3635 | -- | 28.44 | 12.64 | -2,592.27 | -- | 36.16 | -- |
| Neuronetics Inc | 129.87m | -44.50m | 99.99m | 716.00 | -- | 3.65 | -- | 0.7699 | -0.8344 | -0.8344 | 2.24 | 0.3997 | 1.18 | 13.87 | 7.31 | 181,386.90 | -40.63 | -29.61 | -52.56 | -36.96 | 50.43 | 74.98 | -34.35 | -53.71 | 2.09 | -4.31 | 0.6768 | -- | 4.96 | 3.63 | -44.78 | -- | 12.51 | -- |
| Vivani Medical Inc | 0.00 | -26.03m | 102.32m | 42.00 | -- | 59.21 | -- | -- | -0.4417 | -0.4417 | 0.00 | 0.0213 | 0.00 | -- | -- | 0.00 | -76.61 | -43.12 | -94.91 | -49.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 8.44 | -- | 2.43 | -- |
| Hyperfine Inc | 10.59m | -40.05m | 109.69m | 111.00 | -- | 3.26 | -- | 10.36 | -0.5243 | -0.5243 | 0.1385 | 0.3339 | 0.191 | 0.8859 | 1.81 | 95,414.41 | -72.23 | -45.05 | -88.25 | -48.86 | 46.12 | 30.47 | -378.17 | -757.55 | 3.06 | -- | 0.00 | -- | 16.84 | -- | 7.95 | -- | 9.44 | -- |
| Alpha Teknova Inc | 39.80m | -18.22m | 111.88m | 173.00 | -- | 1.54 | -- | 2.81 | -0.3409 | -0.3409 | 0.7446 | 1.36 | 0.3435 | 3.77 | 8.17 | 230,063.60 | -15.73 | -19.57 | -16.94 | -20.97 | 30.97 | 38.24 | -45.78 | -63.70 | 4.27 | -28.65 | 0.1525 | -- | 2.89 | 12.68 | 27.28 | -- | -16.96 | -- |
| Pro-Dex Inc | 70.23m | 11.19m | 119.68m | 181.00 | 11.14 | 2.93 | 9.62 | 1.70 | 3.35 | 3.35 | 21.03 | 12.73 | 1.18 | 2.65 | 4.40 | 388,016.60 | 18.87 | 12.06 | 23.88 | 15.24 | 28.09 | 29.81 | 15.94 | 11.73 | 2.14 | -- | 0.2418 | 0.00 | 23.68 | 13.84 | 322.10 | 7.99 | 19.14 | -- |
| Picard Medical Inc | 4.77m | -33.80m | 123.82m | 75.00 | -- | 15.54 | -- | 25.94 | -0.4673 | -0.4673 | 0.066 | 0.1081 | -- | -- | -- | 63,653.33 | -- | -- | -- | -- | -10.03 | -- | -660.85 | -- | 0.9373 | -0.7808 | 0.0134 | -- | -12.93 | -- | -31.86 | -- | -- | -- |
| Treace Medical Concepts Inc | 218.88m | -50.11m | 133.17m | 477.00 | -- | 1.49 | -- | 0.6084 | -0.7947 | -0.7947 | 3.48 | 1.40 | 1.07 | 1.04 | 7.66 | 458,865.80 | -24.47 | -24.03 | -30.34 | -29.17 | 79.87 | 80.99 | -22.89 | -24.97 | 2.36 | -22.69 | 0.3829 | -- | 11.89 | 39.65 | -12.55 | -- | 57.11 | -- |
Data as of Feb 11 2026. Currency figures normalised to Neuronetics Inc's reporting currency: US Dollar USD
21.67%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Securities LLCas of 31 Dec 2025 | 2.61m | 3.94% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 2.31m | 3.49% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 2.12m | 3.21% |
| Balyasny Asset Management LPas of 30 Sep 2025 | 1.82m | 2.76% |
| Wexford Capital LPas of 30 Sep 2025 | 1.18m | 1.78% |
| Masters Capital Management LLCas of 30 Sep 2025 | 1.00m | 1.51% |
| Marshall Wace LLPas of 30 Sep 2025 | 925.11k | 1.40% |
| Ikarian Capital LLCas of 30 Sep 2025 | 905.72k | 1.37% |
| Geode Capital Management LLCas of 30 Sep 2025 | 876.93k | 1.33% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 587.63k | 0.89% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
